Suxibuzone is a pyrazolidine derivative and a prodrug of phenylbutazone, commonly used as a non-steroidal anti-inflammatory drug in veterinary medicine, particularly for horses. It functions as an anti-inflammatory and analgesic agent in a research and manufacturing context.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 27470-51-5
Noramidopyrine
pharmaceutical raw material
Acemetacin
pharmaceutical raw material
Antipyrine
pharmaceutical raw material
Valdecoxib
pharmaceutical raw material
Aceclofenac-d4 (phenyl-d4-acetoxy)
pharmaceutical raw material
Vildagliptin
pharmaceutical raw material
Haloperidol Decanoate N-Oxide
pharmaceutical raw material
Rac-Sitagliptin-d4 HCl
pharmaceutical raw material
4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid
ONWXNHPOAGOMTG-UHFFFAOYSA-N
CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)COC(=O)CCC(=O)O